06-reference/research

quantum computing 2026 milestone thresholds

2026-05-24·research-brief·source: deep-research

Quantum-computing 2026 — the four named milestone thresholds that would rerank the pecking order

The question

What 2024-2026 quantum-computing commercial milestones (qubit-count, gate-fidelity, useful-algorithm-benchmark) would credibly dethrone the current IonQ/QBTS/RGTI/Quantinuum public-market pecking order in the next 18 months? Founder named quantum (NIST + DOE roadmap) as a candidate orthogonal thesis on 2026-05-12 — the goal here is identifying instrumentation analogous to Innermost-Loop semiconductor-sales anchors, so a quantum-layer thesis has disqualifying-conditions triggers.

What we already know (from the vault)

What the web says

Convergences and contradictions

Synthesis for RDCO

The four threshold-events to instrument for a quantum-layer investing thesis (ordered by disqualifying power):

  1. Logical-qubit count crossing 100 with error rate <1e-6 on a useful algorithm. Quantinuum is at 94 logical qubits / 1e-4 error rate as of March 2026. Crossing 100 LQ and dropping two more orders of magnitude on error rate is the working threshold for "approaching cryptographically-relevant scale." Trigger: track Quantinuum + IBM + Google announcements at AQIS / Q2B / APS March meeting cadence.
  2. Two-qubit gate fidelity crossing five nines (99.999%) on a >100-qubit system. Currently four nines at smaller scale. Five nines at scale is the threshold that unlocks practical fault-tolerant universal computation per the surface-code error-budget literature. IonQ + Silicon Quantum Computing are the leaders to watch. Trigger: rerank pure-play pecking order if IonQ ships first; potentially reranks if a competitor jumps ahead.
  3. First peer-replicated "quantum advantage" on an industry-relevant benchmark. NOT IBM's marketing claim — peer-replicated on something like drug discovery (Quantinuum + Microsoft chemistry simulation), portfolio optimization (D-Wave annealing benchmarks), or cryptanalysis (Shor on a non-trivial integer). Most likely venue: a 2026-Q4 / 2027-Q1 paper from a Quantinuum-Microsoft, IBM-Cleveland-Clinic, or IonQ-Hyundai partnership. Trigger: "quantum advantage" headline counts only if a second team reproduces within 6 months.
  4. NIST PQC migration adoption hitting cloud-provider GA defaults. This is the obligated-dollars anchor analog. By the May 2026 NIST deadline, observe: do AWS / Azure / GCP make PQC the default for TLS 1.3 on free-tier accounts, or only opt-in? Default-on is the "real money is being spent" signal. Trigger: PQC migration rate is a tradeable proxy for the entire quantum-resistance enterprise spend wave (CrowdStrike, Cloudflare, Palo Alto Networks, etc., not the pure-plays).

Why this matters for RDCO specifically: the four pure-plays (IonQ, QBTS, RGTI, Quantinuum-via-Honeywell) are still in trust-the-roadmap territory — none have shipped meaningful revenue tied to quantum-specific deliverables. The investable instrumentation is bifurcated: (a) pure-play roadmap-execution bets (high variance, milestone 1 + 2 are the triggers), and (b) PQC migration adopters (lower variance, milestone 4 is the trigger, but much larger / more diluted exposure). RDCO's existing semiconductor-sales-anchor pattern transfers cleanest to (b), not (a). For (a), the analog is biotech-FDA-trial-readout: milestone-specific binary triggers, not continuous-anchor instrumentation.

Recommendation for the next /investing:build-thesis dispatch: target a "quantum-layer v1" thesis structured around milestone 4 (PQC migration via Cloudflare + cloud-provider TLS defaults), NOT the pure-plays. Save the pure-play thesis for when at least 2 of milestones 1-3 are within 12 months of trigger.

Open follow-ups

Sources

Vault:

Web: